Bernstein Sticks to Their Hold Rating for Wendy's (WEN)
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Gargiulo covers the Consumer Cyclical sector, focusing on stocks such as Starbucks, Chipotle, and CAVA Group, Inc.. According to TipRanks, Gargiulo has an average return of -0.6% and a 49.28% success rate on recommended stocks.
In addition to Bernstein, Wendy's also received a Hold from BTIG's Peter Saleh in a report issued yesterday. However, on the same day, Goldman Sachs maintained a Sell rating on Wendy's (NASDAQ: WEN).
Based on Wendy's' latest earnings release for the quarter ending March 30, the company reported a quarterly revenue of $219.51 million and a net profit of $39.23 million. In comparison, last year the company earned a revenue of $534.75 million and had a net profit of $41.99 million
Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of WEN in relation to earlier this year. Most recently, in May 2025, Kenneth M. Cook, the CFO of WEN bought 1,500.00 shares for a total of $17,025.00.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
NVE Schedules Conference Call on First Quarter Results
EDEN PRAIRIE, Minn., July 16, 2025--(BUSINESS WIRE)--NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter ended June 30, 2025 on Wednesday, July 23, 2025 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time. The quarterly call will be webcast live in a listen-only mode through the Investor Events page of NVE's Website ( An archive of the call will also be available on NVE's Website. To dial into the conference call, parties should call 855-552-4463 inside the United States, or 312-479-9427 and enter Meeting ID 7749 14 3539. Parties may request to ask questions on the call by dialing in or logging into NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. Statements we use that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2025. View source version on Contacts investor@
Yahoo
18 minutes ago
- Yahoo
Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are soaring in Wednesday's after-hours session after the company announced a strategic restructuring and cost-cutting measures. What To Know: After the market close on Wednesday, Sarepta Therapeutics introduced a strategic restructuring plan that involves focusing on high-value, high-impact programs and supporting long-term financials. Sarepta said it initiated immediate changes to reduce operating expenses, including a 36% workforce reduction and a pipeline reprioritization. The changes are expected to drive approximately $400 million in annual cost reductions and lower the company's average annual research and development expenses and selling, general and administrative expenses to between $800 million and $900 million starting in 2026. Sarepta anticipates $100 million in cost savings through the end of 2025. 'Faced with environmental changes, we have decided to act decisively, implementing a focused strategy to ensure Sarepta remains a vibrant, financially enduring, patient-centric organization dedicated to improving the lives of those with rare genetic diseases,' said Doug Ingram, CEO of Sarepta Therapeutics. 'These changes will ensure we remain a financially strong and profitable organization built on a sharpened and focused strategy.' In connection with the announcement, Sarepta reported preliminary financial results for the second quarter. The company said it expects to report second-quarter net product revenue of $513 million. Sarepta had $850 million of cash, cash equivalents, restricted cash and investments as of June 30. The company also announced several new executive leadership changes, including the appointment of Ian Estepan as president and COO and Ryan Wong as CFO. Louise Rodino-Klapac was named president of R&D and technical operations, Rachael Potter was appointed as chief scientific officer and Patrick Moss was named chief commercial officer. SRPT Price Action: Sarepta Therapeutics shares were up 38.08% at $25.38 in after-hours trading at the time of publication Wednesday, according to Benzinga Pro. Read Next: How 340B Drug Discounts Are Driving Up Medicaid Costs By Billions Photo: Shutterstock. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? SAREPTA THERAPEUTICS (SRPT): Free Stock Analysis Report This article Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On? originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Business Wire
20 minutes ago
- Business Wire
Sandisk to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on August 14, 2025
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) announced today that it will hold its fiscal fourth quarter and fiscal year 2025 earnings conference call on Thursday, August 14, 2025, at 1:30 p.m. Pacific time. A live webcast and a webcast replay of the conference call will be available at About Sandisk Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, YouTube. Join TeamSandisk on Instagram. Sandisk and the Sandisk logo are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the U.S. and/or other countries. © 2025 Sandisk Corporation or its affiliates. All rights reserved.
